Trial record 3 of 4 for:    MS and arbaclofen

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Osmotica Pharmaceutical Corporation
ClinicalTrials.gov Identifier:
NCT01743651
First received: November 28, 2012
Last updated: December 5, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)